RUSSELL T. RAY - 19 May 2022 Form 4/A - Amendment Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Russell T. Ray
Issuer symbol
ATNF
Transactions as of
19 May 2022
Net transactions value
+$14,375
Form type
4/A - Amendment
Filing time
29 Jul 2022, 16:16:53 UTC
Date Of Original Report
23 May 2022
Previous filing
18 Jan 2022
Next filing
29 Jul 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Award $14,375 +10,570 +224% $1.36 15,298 19 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNF Non-Qualified Stock Option (right to buy) Award $0 +21,000 $0.000000 21,000 19 May 2022 Common Stock 21,000 $1.36 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in consideration for serving on the Board of Directors and as a Member of the Audit, Compensation and Nominating and Corporate Governance Committees of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
F2 Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
F3 The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the following 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.

Remarks:

This Form 4/A is being filed to correct the number of shares held by the Reporting Person after the transaction reported above which was incorrect in the original filing.